Boehringer Ingelheim GmbH’s Dabigatran: The Case of the Missing 110-mg Dose, Brigham and Women’s Hospital Study

MedPageToday -- The mystery surrounding the doses of dabigatran (Pradaxa) approved this week by the FDA has not yet been fully solved, but the FDA has provided a partial answer.

MORE ON THIS TOPIC